Abstract
Saturated very long chain fatty acids (fatty acids with greater than 22 carbon atoms; VLCFA) accumulate in peroxisomal disorders, but there is little information on their turnover in patients. To determine the suitability of using stable isotope-labeled VLCFA in patients with these disorders, the metabolism of 22-methyl[23,23,23-2H3]tricosanoic (iso-lignoceric) acid was studied in rats in vivo and in human skin fibroblasts in culture. The deuterated iso-VLCFA was degraded to the corresponding 16- and 18-carbon iso-fatty acids by rats in vivo and by normal human skin fibroblasts in culture, but there was little or no degradation in peroxisome-deficient (Zellweger’s syndrome) fibroblasts, indicating that its oxidation was peroxisomal. Neither the 14-, 20-, and 22-carbon iso-fatty acids nor the corresponding odd-chain metabolites could be detected. In the rat, the organ containing most of the iso-lignoceric acid, and its breakdown products, was the liver, whereas negligible amounts were detected in the brain, suggesting that little of the fatty acid crossed the blood-brain barrier. Our data indicate that VLCFA labeled with deuterium at the ω-position of the carbon chain are suitable derivatives for the in vivo investigation of patients with defects in peroxisomal β-oxidation because they are metabolized by the same pathways as the corresponding n-VLCFA. Moreover, as iso-VLCFA and their β-oxidation products are readily separated from the corresponding n-fatty acids by normal chromatographic procedures, the turnover of VLCFA can be more precisely measured.
Similar content being viewed by others
Abbreviations
- ALD:
-
adrenoleukodystrophy
- BME:
-
basal Eagle’s medium
- iso-fatty acids:
-
fatty acids with a methyl branch at the ω-2 position
- iso-lignoceric acid, iso-24∶0:
-
22-methyl tricosanoic acid
- lignoceric acid:
-
24∶0, tetracosanoic acid
- n-fatty acids:
-
straight chain fatty acids
- VLCFA:
-
fatty acids with greater than 22 carbon atoms
References
O’Brien, J.S., and Sampson, E.L. (1965) Fatty Acid and Fatty Aldehyde Composition of the Major Brain Lipids in Normal Human Gray Matter, White Matter, and Myelin, J. Lipid Res. 6, 545–551.
Kugi, M., Yoshida, S., and Takeshita, M. (1990) Characterisation of Fatty Acid Elongation System in Porcine Neutrophil Microsomes, Biochim. Biophys. Acta 1043, 83–90.
Singh, H., Derwas, N., and Poulos, A. (1987) Very Long Chain Fatty Acid β-Oxidation by Rat Liver Mitochondria and Peroxisomes, Arch. Biochem. Biophys. 259, 382–390.
Singh, H., and Poulos, A. (1988) Distinct Long Chain and Very Long Chain Fatty Acyl CoA Synthetases in Rat Liver Peroxisomes and Microsomes, Arch. Biochem. Biophys. 266, 486–495.
Singh, I., Moser, A.B., Goldfischer, S., and Moser, H.W. (1984) Lignoceric Acid Is Oxidized in the Peroxisome: Implications for the Zellweger Cerebro-Hepato-Renal Syndrome and Adrenoleukodystrophy, Proc. Natl. Acad. Sci. USA 81, 4203–4207.
Singh, H., Derwas, N., and Poulos, A. (1987) Very Long Chain Fatty Acid β-Oxidation by Subcellular Fractions of Normal and Zellweger Syndrome Skin Fibroblasts, Arch. Biochem. Biophys. 257, 302–314.
Street, J.M., Singh, H., and Poulos, A. (1990) Metabolism of Saturated and Polyunsaturated Very-Long-Chain Fatty Acids in Fibroblasts from Patients with Defects in Peroxisomal β-Oxidation, Biochem. J. 269, 671–677.
Hayashi, H., and Oohashi, M. (1995) Incorporation of Acetyl-CoA Generated from Peroxisomal β-Oxidation into Ethanolamine Plasmalogen of Rat Liver, Biochim. Biophys. Acta 1254, 319–325.
Christiansen, E.N., Thomassen, M.S., Christiansen, R.Z., Osmundsen, H., and Norum, K.R. (1979) Metabolism of Erucic Acid in Perfused Rat Liver. Increased Chain Shortening After Feeding Partially Hydrogenated Marine Oil and Rapeseed Oil, Lipids 14, 829–835.
Bartlett, K., Hovik, R., Watmough, N.J., and Osmundsen, H. (1990) Intermediates of Peroxisomal β-Oxidation. A Study of the Fatty Acyl-CoA Esters Which Accumulate During Peroxisomal β-Oxidation of [U-14C]-Hexadecanoate, Biochem. J. 270, 175–180.
Osmundsen, H.O., Bremer, J., and Pedersen, J.I. (1991) Metabolic Aspects of Peroxisomal β-Oxidation, Biochim. Biophys. Acta 1085, 141–158.
Mosser, J., Douar, A.M., Sarde, C.O., Kioschis, P., Feil, R., Moser, H., Poutska, A.M., Mandel, J.M., and Aubourg, P. (1993) Putative X-Linked Adrenoleukodystrophy Gene Shares Unexpected Homology with ABC Transporters, Nature 361 726–730.
Kok, F., Neumann, S., Sarde, C.O., Zheng, S., Wu, K.-H., Wei, H.-M., Bergin, J., Watkins, P.A., Gould, S., Sack, G., Moser, H., Mandel, J.-L., and Smith, K.D. (1995) Mutational Analysis of Patients with X-Linked Adrenoleukodystrophy, Hum. Mutat. 6, 104–115.
Moser, H.W., Moser, A.B., Smith, K.D., Bergin, A., Borel, J., Shankroff, J., Stine, O.C., Merette, C., Ott, J., Krivit, W., and Shapiro, E. (1992) Adrenoleukodystrophy: Phenotypic Variability: Implications for Therapy, J. Inherit. Metab. Dis. 15, 645–664.
Moser, H.W., Bergin, A., and Cornblath, D. (1991) Peroxisomal Disorders, Biochem. Cell Biol. 69, 463–474.
Wanders, R.J.A., van Roermund, C.W.T., van Wijland, M.J.A., Schutgens, R.B.H., Heikoop, J., van den Bosch, H., Schram, A.W., and Tager, J.M. (1987) Peroxisomal Fatty Acid β-Oxidation in Relation to the Accumulation of Very Long Chain Fatty Acids in Cultured Skin Fibroblasts from Patients with Zellweger Syndrome and Other Peroxisomal Disorders, J. Clin. Invest. 80, 1778–1783.
Wanders, R.J.A., van Roermund, C.W.T., Lageweg, W., Jakobs, B.S., Schutgens, R.B.H., Nijenhuis, A.A., and Tager, J.M. (1992) X-Linked Adrenoleukodystrophy: Biochemical Diagnosis and Enzyme Defect, J. Inherit. Metab. Dis. 15, 634–644.
Johnson, D.W., Stockham, P.C., Beckman, K., Paton, B.C., and Poulos, A. (1995) Probing the Metabolism of Very Long Chain Fatty Acids with Deuterated Isolignoceric Acid, in Synthesis and Applications of Isotopically Labelled Compounds (Allen, J., and Voges, R., eds.), pp. 839–842, John Wiley & Sons Ltd., Chichester, England.
Johnson, D.W., and Poulos, A. (1988) Syntheses of Deuterium-labelled Pristanic and Phytanic Acids, Chem. Phys. Lipids 48, 141–146.
Johnson, D.W. (1990) A Synthesis of Unsaturated Very Long Chain Fatty Acids, Chem. Phys. Lipids 56, 65–71.
Bradford, M.M. (1976) A Rapid and Sensitive Method for the Quantitation of Microgram Quantitites of Protein Utilising the Principle of Protein-Dye Binding, Anal. Biochem. 72, 248–254.
Bligh, E.G., and Dyer, W.J. (1959) A Rapid Method of Total Lipid Extraction and Purification, Can. J. Biochem. Physiol. 37, 911–917.
Sharp, P., Poulos, A., Fellenberg, A.J., and Johnson, D. (1987) Structure and Lipid Distribution of Polyenoic Very-Long-Chain Fatty Acids in the Brain of Peroxisome-Deficient Patients (Zellweger syndrome), Biochem. J. 248, 61–67.
Poulos, A., Singh, H., Paton, B.C., Sharp, P., and Derwas, N. (1986) Accumulation and Defective β-Oxidation of Very Long Chain Fatty Acids in Zellweger’s Syndrome, Adrenoleukodystrophy, and Refsum’s Disease Variants, Clin. Genet. 29, 397–408.
Suzuki, Y., Shimozawa, N., Yajima, S., Orii, T., Yokota, S., Tashiro, Y., Osumi, T., and Hashimoto, T. (1992) Different Intracellular Localization of Peroxisomal Proteins in Fibroblasts from Patients with Aberrant Peroxisome Assembly, Cell Struct. Function 17, 1–8.
Kishimoto, Y., Moser, H.W., Kawamura, N., Platt, M., Pallante, S.L., and Fenselau, C. (1980) Adrenoleukodystrophy: Evidence that Abnormal Very Long Chain Fatty Acids of Brain Cholesterol Esters Are of Exogenous Origin, Biochem. Biophys. Res. Commun. 96, 69–76.
Poulos, A., Gibson, R., Sharp, P., Beckman, K., and Grattan-Smith, P. (1994) Very Long Chain Fatty Acids in X-Linked Adrenoleukodystrophy Brain After Treatment with Lorenzo’s Oil, Ann. Neurol. 36, 741–746.
Rasmussen, M., Moser, A.B., Borel, J., Khangoora, S., and Moser, H.W. (1994) Brain, Liver, and Adipose Tissue Erucic Acid and Very Long Chain Fatty Acid Levels in Adrenoleukodystrophy Patients Treated with Glycerol Trierucate and Trioleate Oil (Lorenzo’s oil), Neurochem. Res. 19, 1073–1082.
Tsuji, S., Sano-Kawamura, T., Ariga, T., and Miyatake, T. (1985) Metabolism of [17,18-3H2]Hexacosanoic Acid and [15, 16-3H2]Lignoceric Acid in Cultured Skin Fibroblasts from Patients with Adrenoleukodystrophy (ALD) and Adrenomyeloneuropathy (AMN), J. Neurol. Sci. 71, 359–367.
Poulos, A., Sharp, P., Singh, H., Johnson, D.W., Carey, W.F., and Easton, C. (1993) Formic Acid Is a Product of the α-Oxidation of Fatty Acids by Human Skin Fibroblasts: Deficiency of Formic Acid Production in Peroxisome-Deficient Fibroblasts, Biochem. J. 292, 457–461.
Singh, H., Usher, S., Johnson, D., and Poulos, A. (1990) A Comparative Study of Straight Chain and Branched Chain Fatty Acid Oxidation in Skin Fibroblasts from Patients with Peroxisomal Disorders, J. Lipid Res. 31, 217–225.
Kemp, S., Wei, H.-M., Lu, J.-F., Braiterman, L.T., McGuinness, M.C., Moser, A.B., Watkins, P.A., and Smith, K.D. (1998) Gene Redundancy and Pharmacological Gene Therapy: Implications for X-Linked Adrenoleukodystrophy, Nature Medicien 4, 1261–1268.
Singh, I., Khan, M., Key, L., and Pai, S. (1998) Lovastatin for X-Linked Adrenoleukodystrophy, New Engl. J. Med. 339, 702–703.
Author information
Authors and Affiliations
Corresponding author
Additional information
A preliminary report of part of this work (Reference 18) was presented at the 5th International Symposium on the Synthesis and Applications of Isotopes and Isotopically Labelled Compounds, Strasbourg, France, June 20–24, 1994.
About this article
Cite this article
Poulos, A., Stockham, P.C., Johnson, D.W. et al. Metabolism of trideuterated iso-lignoceric acid in rats in Vivo and in human fibroblasts in culture. Lipids 34, 943–949 (1999). https://doi.org/10.1007/s11745-999-0444-y
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11745-999-0444-y